16-30 of 285
Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting
MinuteCE®Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting
NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
MinuteCE®NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
MinuteCE®Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
Novel RAS-Targeted Therapy: Prevention, Monitoring, and Mitigation of Adverse Events
MinuteCE®Novel RAS-Targeted Therapy: Prevention, Monitoring, and Mitigation of Adverse Events
RAS(ON) and Beyond: Clinical Integration and Strategic Sequencing
MinuteCE®RAS(ON) and Beyond: Clinical Integration and Strategic Sequencing
Frontline Insights: Emerging Therapeutic Strategies in HNSCC
CME/CEFrontline Insights: Emerging Therapeutic Strategies in HNSCC
- advertisement
Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
CME/CEBreaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
Interdisciplinary Strategies for BRCA-Mutated EBC: Testing, Targeting, and Team-Based Care
CME/CE Broadcast ReplayInterdisciplinary Strategies for BRCA-Mutated EBC: Testing, Targeting, and Team-Based Care
Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CEAddressing Unmet Needs in Metastatic Uveal Melanoma
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
CME/CEPatients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
MinuteCE®The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
- advertisement
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
MinuteCE®Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
MinuteCE®Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
MinuteCE®Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
